Navigation Links
Tobira's Next-Generation Once-Daily CCR5 Receptor Antagonist Demonstrates Efficacy, Safety and Tolerability in Treatment-Experienced Patients With HIV
Date:2/17/2010

SAN FRANCISCO, Feb. 17 /PRNewswire/ -- The first-ever-reported Phase II data for TBR-652, which is being developed by Tobira Therapeutics for the treatment of HIV infection, demonstrate that the CCR5 receptor antagonist provides potent antiviral activity and is generally safe and well-tolerated in its proof of concept trial. The data were released here today in an oral presentation at the 17th Conference on Retroviruses and Opportunistic Infections (CROI).

In a Phase IIa trial involving 54 treatment-experienced HIV infected patients, a 10-day course of once-daily, TBR-652 monotherapy produced a median nadir decline from baseline in HIV viral load of up to 1.8 log10 copies/mL. There were no serious adverse events, deaths or study drug-related discontinuations in the study.  Dose dependent changes in MCP-1 concentrations were also observed, demonstrating TBR-652's dual CCR5/CCR2 mechanism of action and potential anti-inflammatory benefits.  

"These data demonstrate that TBR-652 offers potent viral suppression and excellent safety and tolerability in this short-term study," observed Calvin J. Cohen, M.D., M.Sc., of the Community Research Initiative of New England. "This compound provides the potential for once-daily dosing, without the need for a pharmacologic boosting agent, an important benefit for simplified dosing and ease of administration in early stage disease."

Dr. Cohen presented data from Study 652-2-201, a double-blind, placebo-controlled, dose-escalation trial in which patients were randomized four-to-one to receive doses of TBR-652 of 25mg, 50mg, 75mg, 100mg, 150mg and placebo.  

All patients were HIV treatment-experienced, though none had previously been treated with a CCR5 antagonist. Most adverse events in the study were mild in severity (Grade 1). There were no clin
'/>"/>

SOURCE Tobira Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. The Oclaro Next-Generation Orion Fiber-Coupled Diode Laser Raises the Bar for Performance, Cost and Reliability for Solid State Lasers
2. WorldHeart Signs Agreements for Next-Generation Minimally Invasive Blood Pump
3. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
4. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
5. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
6. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
7. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
8. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
9. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
10. ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay(TM)
11. Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) ... Life Science Firm of the Year by the Tech Council ... at the TCM,s 25 th Annual Tech Awards Celebration ... Awards Celebration recognizes the leaders and innovators in the technology ... and the surrounding regions. "We are deeply ...
(Date:5/23/2013)... 2013 Nephros, Inc. (OTC Bulletin Board: ... that develops and sells high performance liquid purification ultrafilters, ... In addition, the concurrent temporary reduction in exercise price ... 17, 2013. Nephros estimates that it will ... offering.   A portion of the proceeds will be used ...
(Date:5/23/2013)... -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a ... intellectual property developed and owned by Hadassah University ... research center, today announced that its portfolio company, ... the Israeli Ministry of Industry and Commerce, Office ... development and advance clinical trials. Cell Cure,s development ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... HARRISBURG, Pa., Nov. 16 Consumers who have,purchased raw ... any time after Oct. 23, should discard it immediately ... Wolff,said today. Raw milk is milk that has ... of the dairy, a preliminary test showed the,presence of ...
... half of,health care workers get an annual flu shot, ... and the federal Centers for Disease,Control of the need ... is plenty of vaccine available this season, so there ... shot," said Joanne Grossi, deputy,secretary for health promotion and ...
Cached Medicine Technology:State, Federal Officials Remind Health Care Workers, Other at-Risk Individuals to Get Annual Flu Shot 2
(Date:5/25/2013)... Many viruses and parasites that affect both dogs and ... illness than can result in liver or kidney failure ... a veterinarian. These germs could be found ... Dr. Susan Nelson, a clinical associate professor at Kansas ... diseases can be fatal, even with treatment," she said ...
(Date:5/25/2013)... Radius Engineering International Inc., is ... the US and has been building concrete, steel, ... years. M.E. and President, Walton McCarthy, author of ... Fundamentals and Shelter Engineering Standards, Sixth Edition, 2012, ... engineering. McCarthy is considered the leading expert in ...
(Date:5/25/2013)... Absolute Surgical Specialists, serving Sun City Center for ... throughout the country participating in Shop Local for a Cause. ... event as he understands what military families go through after ... said, “I wanted to give something back, as I not ... here too.” , Shop Local for a Cause has chosen ...
(Date:5/25/2013)... 2013 The latest report from ... bowel syndrome (IBS) to bloating, constipation, diarrhea and ... long-lasting, embarrassing, frustrating and difficult health issues to ... health have provided a cure for these ... contributing to digestive health issues, a healthy diet ...
(Date:5/25/2013)... May 25, 2013 According to ... Management Market, 2013–2018", published by MarketsandMarkets is expected ... CARC of 5.54% which analyzes and studies the ... America, Europe, Asia, and Rest of the World. ... Data Tables , 87 Figures , ...
Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4
... also repair damaged ankles claim the researchers. ,Arthroscopy ... but it is also a valuable method for treating ... technique it is being applied in new ways by ... damage, bone chips and recurrent pain from end-stage arthritis. ...
... disease, is becoming an elite disease as so much of ... As a result of such ongoing research, hyperhomocysteinemia (increased levels ... the risk factors.// ,Dr. O Mayer Jr and colleagues ... result of their study that beer may provide enough folate--a ...
... strike a pot of gold by making cheap anti-AIDS ... likely to escalate in coming days. ,The large ... develop anti-AIDS drugs and market it in India and ... anti-AIDS drug market, currently dominated by Mumbai-based Cipla, witnessed ...
... health"- this warning , printed in every cigarette carton ,had been ... many. But now the fact that even a single cigarette is ... of North Carolina. ,It is a well known fact that ... as heart attack , cancer etc.,. Dr. Firas A. ...
... improve mood and reduce fatigue, study reports. ,It is a ... asset. But as far as mental fatigue is concerned, there was ... based on the preliminary findings which included 14 women who did ... benefits as far as mood is concerned. ,Cheryl J. Hansen ...
... Crohn's disease and ulcerative colitis, often grouped together ... of modern, industrialized nations with stringent standards of ... prevents the human immune system from interacting with ... to develop properly...Yes! Doctors at the University of ...
Cached Medicine News:Health News:Arthroscopy for Ankles 2Health News:WORM! WORM! all the way 2
... The Ankle Cryo/Cuff combines the therapeutic ... and swelling, and cold to minimize pain. ... fit the ankle providing maximum cryotherapy. The ... is also available in a pediatric size.,All ...
... combines the clinically proven Air-Stirrup Ankle ... addition, a comprehensive instruction booklet is ... provides information on treatment and rehabilitation ... management.,Each Air-Stirrup Ankle Brace features anatomically ...
... the Aircast VenaFlow System (a prophylaxis for ... different styles: calf, foot, and thigh, to ... made from light, cool, comfortable material to ... may be placed directly against the skin. ...
Comfor™ Cast Boot - Rocker Sole - Closed Toe...
Medicine Products: